Univ. research defends big pharma, aids addiction epidemic

The medical school at the University of Wisconsin conducts research in favor of pharmaceutical companies in exchange for millions of dollars of funding from companies like Purdue Pharma, makers of OxyContin, found a new investigation by Journal Sentinel/MedPage. Beginning in 2006, when the U.S. Centers for Disease Control and Prevention issued a report connecting deaths from prescription drugs to a 500 percent increase in prescriptions, the university began issuing their own warnings against any attempt to increase regulation of the drugs. According to the investigation, the school’s reports liberalized the prescribing practices of highly-addictive Schedule II narcotics and may have directly influenced the addiction epidemic currently raging in the U.S.

Some advocacy groups are now calling on Chancellor Biddy Martin to shut down UW’s Pain and Policy Group, which lobbies for the de-regulation of narcotic pain medicine. If you’d like to weigh in, email the chancellor or call (608) 262-9946. Here is a sample letter from Pete Jackson, the president of Advocates for the Reform of Prescription Opioids.

About Dana Owens

Dana Owens is San Francisco-based writer, editor and blogger who works on diverse projects from holistic health research to record label promotion. In addition to lending her editorial eye to Oxy Watchdog, Dana also acts as copyeditor for 99 Series, Inc. and executive assistant/project coordinator for Heartline Productions.
This entry was posted in Pain Advocates, Pharmaceutical Industry and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *